Project reports

Database of our projects

Since 1998 until 2013 we promoted more than 30 projects, whose details including abstracts and some final reports you will find under the following Links.

Projekt 50
- Development of AAV-mediated gene therapy for hereditary spastic paraplegia
Projekt 49
- Characterization of ap4b1-/- zebrafish as a novel in vivo model of SPG47 and its application in small molecule screens
Projekt 48
- Scouting biological effects of miglustat in subjects with Spastic Paraplegia type 11
Project 47
- Boosting spastin microtubule-severing activity through TTLL-mediated tubulin polyglutamylation: a novel therapeutic strategy in SPG4-linked Hereditary Spastic Paraplegia.
Projekt 46
- In vivo and ex vivo Characterization of a novel spastic paraplegia rescue knockout mouse model to define the therapeutic potential of somatic gene repair in HSP
Projekt 45
- Systematic identification of noncoding tandem repeat expansions in unresolved cases of spastic paraplegias and spinocerebellar ataxias using a combination of short- and long-read sequencing technologies
Projekt 44
- From Pathophysiology to Therapeutic Targets: Disturbed Sphingolipid Metabolism in HSP Caused by GBA2 Mutations
Projekt 43
- Physical Exercise as a Possible Therapy for Hereditary Spastic Paraplegia Type 2
Projekt 42
- Therapeutic strategies to treating hereditary spastic paraplegias
Projekt 41
- Patient-specific model of adipose-brain axis dysregulation in SPG11 hereditary spastic paraplegias
- final report
Projekt 40
- Investigating a novel phenotype of lysosomal dysfunction in spartin-HSP
Project 39 advanced scholarship 2016 II
- Defining the therapeutic potential of somatic gene repair for hereditary spastic paraplegia
Project 38 advanced scholarship 2016 I
- Therapies for SPG4-HSP using a new genetic mouse expressing mutant human SPAST
Testing molecular models of SPG11 function in the fruitfly Drosophila
- Testing molecular models of SPG11 function in the fruitfly Drosophila
- The o'Kane Team
Project 36
- NGS to identify new genes in recessive HSP diseases and their functional validation
Project 35
- Mouse models for SPG11 and SPG49 diseases.
- The Paris Team
- Final report
Dynamic evaluation of spasticity in patients with hereditary spastic paraplegias
- Dynamic evaluation of spasticity in patients with hereditary spastic paraplegias
- the team
Charakterisation of an interacting network of proteins that regulate endosomal tubulation and the HSP phenotype
- Characterisation of an interacting network of proteins that regulate endosomal tubulation and the HSP phenotype
- The team
- Final report
Project 32 advanced scholarship 2
- Abnormalities of lipid droplet biogenesis: a novel pathogenic twist in hereditary spastic paraplegia
Project 31
- Paris - Conference
- Final report
Project 30
- Unraveling the molecular basis of hereditary spastic paraplegias –
- Final report
Project 29
- Analysis of the cellular functions of the Dictyostelium strumpellin ortholog.
- Researcher group
Project 28
- Identification of mutated genes in novel forms of HSP
- the research group
- Final report
advanced scholarship
- Our anniversary project 2009
Project 26
- Characterising a novel form of complicated hereditary spastic paraplegia
- Final report
Project 25
- Treadmill-training in Hereditary Spastic Paraplegia: Effects on Cortico-Spinal Reflex-modulation, Walking und Quality of Life
Project 24
- Intracellular Sort- and Transportsystems in HSP - in vitro and in vivo models for testing the role of Atlastin and KIF5A
Project 23
- Generation of a mouse model for Zfyve27, the gene which is mutated in hereditary spastic paraplegia (SPG33)
- Final report
Project 22
- The Molecular Pathology of NIPA1-associated Hereditary Spastic Paraplegia
Project 21
- Candidate gene- analysis at complicated HSP with thin Corpus Callosum (SPG11)
Project 21A
- How to charcterize spezific interaktion partner of Atlastin1
Project 20
- Screening for disease-associated copy number aberrations in autosomal dominant hereditary spastic paraplegia using multiplex ligation-dependent probe amplification (MLPA)
Project 19
- Efficacy and safety of levodopa treatment in patients with hereditary spastic paraplegia (HSP)
Project 18
- Refinement of the SPG5 locus and identification of candidate genes and mutations in SPG5- and SPG30-positive families
- Final report
Project 17
- Towards a cellular and molecular understanding of hereditary spastic paraplegia:
Project 16
- Nipa1 function and mouse models for hereditary spastic paraplegia
Project 15
- Comparison of Physiotherapy Methods Using Hereditary Spastic Spinal Paralysis (HSP) as Example
Project 14
- Investigations of the familial and social situation, coping strategies and opinions of people, suffering from hereditary spastic paraplegia and of their relatives to genetic diagnosis
Project 13
- Checking patients with simple an complicated HSP by DTI to find subtyping of the heterogeneous group of disease
- final reports
Project 12
- The FSP- research team at Jena under leadership from Prof. Deufel operates at present a project for functional characterization of spastin.
Project 11
- Screening for disease-associated copy number aberrations in autosomal dominant hereditary spastic paraplegia using multiplex ligation-dependent probe amplification
Project 10
- Troyer Syndrom (SPG 20 ) genetic and functional analysis of a microtubli-associated disease
- Final reporting
Project 9
- Nipa1 function and mouse models for hereditary spastic paraplegia
Project 8
- Construction of a SPG1- and SPG4- Tetanus-Toxin-Hybridprotein for the intraneuronal transport of the L1-CAM and Spastin-Protein – model of a new therapy method?
Project 6
- Clinical trial of medical condition in combination with HSP including the physiotherapeutical treatment
Project 5
- Indentifying gene of silver syndrome by verification of mutations
Project 4
- Hereditary spastic paraparesis with amyotrophy of the hands (Silver syndrome): Cellular expression analysis of the mutated Silver gene
Project 7
- Reconstitution of neural functions in the spinal cord through neural stem cells expressing the neural cell adhesion molecule L1
Project 3a
- mutation analysis on families with HSP and some without family history
- Applicant Dr. Alba
- final report
Project 3
- Isolation of peptides binding to the neural cell adhesion molecule L1 that enhance neurite outgrowth and neuronal survival
- Final report
Project2
- Clinical and molecular-genetic characterization of patients
Project 1
- Evaluation of treatment of HSP with Ritalin
- Final report given at the TWS Symposium Nr. 2 at Kassel 2002

Database of our projects

Spendenkonto

Kontakt